Phenotypic approach to the Management of chronic prostatitis/chronic pelvic pain syndrome

被引:14
|
作者
Nickel J.C. [1 ]
Shoskes D. [1 ]
机构
[1] Department of Urology, Queen's University, Kingston General Hospital, Kingston, ON K7L 2V7
基金
美国国家卫生研究院;
关键词
Pregabalin; Prostatitis; Tamsulosin; Interstitial Cystitis; Chronic Prostatitis;
D O I
10.1007/s11934-009-0050-7
中图分类号
学科分类号
摘要
There is no one unifying etiological mechanism or specific curative therapy for chronic prostatitis/ chronic pelvic pain syndrome (CP/CPPS). However, there is sufficient evidence to suggest that each of the proposed mechanisms may be important in some patients, and that many of our evaluated treatments do in fact work in subgroups of patients. We hypothesize that CP/CPPS patients are not a homogenous group suffering from a single disease entity. Rather, CP/CPPS patients are actually unique individuals with differing clinical phenotypes based on various etiological mechanisms with distinctive symptom complexes and progression trajectories. We call this the "Snow Flake Hypothesis." We propose the UPOINT (urinary, psychosocial, organ-specific, infection, neurologic/systemic, and tenderness domains) clinical phenotyping classification; we have validated the concept in a CP/CPPS cohort and have suggested that phenotypically directed therapy will improve our clinical treatment outcomes. Copyright © 2009 by Current Medicine Group LLC.
引用
收藏
页码:307 / 312
页数:5
相关论文
共 50 条
  • [41] Apremilast in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Pilot Study
    McLennan, Gregory P.
    Khourdaji, Iyad
    Killinger, Kim A.
    Boura, Judith A.
    Peters, Kenneth M.
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2012, 4 (03) : 140 - 143
  • [42] Summary consensus statement: Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome
    Schaeffer, AJ
    Weidner, W
    Barbalias, GA
    Botto, H
    Johansen, TEB
    Hochreiter, WW
    Krieger, JN
    Lobel, B
    Naber, KG
    Nickel, JC
    Potts, JM
    Tenke, P
    Hart, C
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (02) : 1 - 4
  • [43] Update on minimally invasive therapy for chronic prostatitis/chronic pelvic pain syndrome
    Kastner C.
    Current Urology Reports, 2008, 9 (4) : 333 - 338
  • [44] Chronic pelvic pain syndrome: Diagnosis and management
    Jeannette M. Potts
    Current Urology Reports, 2003, 4 (4) : 316 - 319
  • [45] Acute bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: andrological implications
    Weidner, W.
    Wagenlehner, F. M. E.
    Marconi, M.
    Pilatz, A.
    Pantke, K. H. P.
    Diemer, T.
    ANDROLOGIA, 2008, 40 (02) : 105 - 112
  • [46] Chronic Prostatitis/Chronic Pelvic Pain Syndrome: a Literature Review of NIH III Prostatitis
    Thomas Farmer
    Max Johnston
    Alina Milica
    Richard Hindley
    Amr Emara
    Current Bladder Dysfunction Reports, 2019, 14 : 83 - 89
  • [47] IBS and Chronic Prostatitis: Update on Chronic Pelvic Pain
    Eltahawy, Ehab
    Lelovic, Nada
    Quallich, Susanne
    Machado, Bruno
    CURRENT BLADDER DYSFUNCTION REPORTS, 2024, 19 (02) : 171 - 179
  • [48] Chronic Prostatitis/Chronic Pelvic Pain Syndrome: a Literature Review of NIH III Prostatitis
    Farmer, Thomas
    Johnston, Max
    Milica, Alina
    Hindley, Richard
    Emara, Amr
    CURRENT BLADDER DYSFUNCTION REPORTS, 2019, 14 (02) : 83 - 89
  • [49] Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline
    Rees, Jon
    Abrahams, Mark
    Doble, Andrew
    Cooper, Alison
    BJU INTERNATIONAL, 2015, 116 (04) : 509 - 525
  • [50] α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome
    Thakkinstian, Ammarin
    Attia, John
    Anothaisintawee, Thunyarat
    Nickel, J. Curtis
    BJU INTERNATIONAL, 2012, 110 (07) : 1014 - 1022